Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
463.50    2.00 (0.43%)
Bid:
459.00
Ask:
463.50
Spread: 4.50 (0.98%)
Market Cap: £160.99m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director/PDMR Shareholding

17 Sep 2020 12:18

RNS Number : 3290Z
Frontier Developments PLC
17 September 2020
Β 

Frontier Developments plc

ExerciseΒ of Options, Director/PDMR Shareholding and Total Voting Rights

Frontier Developments plc (AIM: FDEV, "Frontier", the "Company") announces that on 16 September 2020 in aggregate options over 21,189 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") were exercised under the Company's share option plans. Of the Ordinary Shares exercised, David Walsh, a Director of the Company, exercised 7,389 share options (the "Options") and subsequently sold 7,389 Ordinary Shares. The Company was also notified that Ann Cotton, a person closely associated ("PCA") with Charles Cotton, a Director of the Company, sold 1,927 Ordinary Shares on 16 September 2020.

The Options exercised and Ordinary Shares sold by the Director and PCA are set out in the tables below, together with the total number of Ordinary Shares each Director is interested in and holds under option.

Β 

Name of Director

Role

Number of Options exercised

Exercise price of Options exercised

Total Number of Options held following the exercise

David Walsh

Non-Executive Director

7,389

406p

23,648

Β 

Resultant Holding

Name of Director / PCA

Role

Ordinary shares sold

Price of Ordinary shares sold

Number of Ordinary Shares held following the sale

Percentage of issued share capital

David Walsh

Non-Executive Director

7,389

2,601p

3,500

0.01%

Ann Cotton

PCA of Non-Executive Director

1,927

2,598p

154,659(1)

0.39%(1)

Β 

(1)Including Charles Cotton's direct family holdings

Β 

Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that, following the exercise of Options, its issued share capital consists of 39,199,088 Ordinary Shares.

The Company does not currently hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 39,199,088.

Β 

The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Β 

Β 

Enquiries:

Β 

Frontier DevelopmentsΒ Β +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFOΒ 

Β 

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Β 

Jefferies - Joint BrokerΒ Β +44 (0)20 7029 8000

Max Jones / William Brown

Β 

Tulchan CommunicationsΒ Β +44 (0)20 7353 4200

Matt Low / Deborah Roney / David Allchurch

Β 

Β 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

Β 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1. Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Walsh

2. Β 

Reason for the notification

a)

Position/status: Non-Executive Director

b)

Initial notification/Amendment: Initial Notification

3. Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4. Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

a) Exercise of Options

b) Disposal of Ordinary Shares

c)

Β 

Β 

Price(s) and volume(s):

a)

Exercise Price(s)

Volume(s)

406p

7,389

Β 

b)

Sale Price(s)

Volume(s)

2,601p

7,389

d)

Aggregated information:

a) n/a - Single transaction

b) n/a - Single transaction

Β 

Β 

e)

Date of the transaction(s): 16 September 2020

f)

Place of the transaction:

a) Outside a trading venue

b) London Stock Exchange

Β 

1. Β 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Ann Cotton, PCA of Charles Cotton

2. Β 

Reason for the notification

a)

Position/status: PCA of a Non-Executive Director

b)

Initial notification/Amendment: Initial Notification

3. Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4. Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

Disposal of Ordinary Shares

Β 

c)

Β 

Β 

Price(s) and volume(s):

Sale Price(s)

Volume(s)

2,598p

1,927

d)

Aggregated information:

n/a - Single transaction

Β 

e)

Date of the transaction(s): 16 September 2020

f)

Place of the transaction:

a) London Stock Exchange

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKKOBDDBKDACD
Date   Source Headline
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
16th Dec 20257:00 amRNSCEO TRANSITION
14th Nov 20251:37 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSA STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO
5th Nov 20258:57 amRNSHolding(s) in Company
29th Oct 202510:48 amRNSResult of AGM
21st Oct 20253:00 pmRNS-RJURASSIC WORLD EVOLUTION 3 IS OUT NOW!

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.